Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other financing activities: 2009-2020

Historic Other financing activities for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Dec 2020 value amounting to $135,405.

  • Cumberland Pharmaceuticals' Other financing activities fell 232.30% to -$370,464 in Q1 2022 from the same period last year, while for Mar 2022 it was -$650,484, marking a year-over-year decrease of 409.86%. This contributed to the annual value of $135,405 for FY2020, which is 86.46% down from last year.
  • According to the latest figures from FY2020, Cumberland Pharmaceuticals' Other financing activities is $135,405, which was down 86.46% from $1.0 million recorded in FY2019.
  • Cumberland Pharmaceuticals' Other financing activities' 5-year high stood at $1.0 million during FY2019, with a 5-year trough of -$1.0 million in FY2016.
  • For the 3-year period, Cumberland Pharmaceuticals' Other financing activities averaged around $506,238, with its median value being $383,310 (2018).
  • In the last 5 years, Cumberland Pharmaceuticals' Other financing activities plummeted by 161.53% in 2016 and then skyrocketed by 320.72% in 2018.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Other financing activities stood at -$1.0 million in 2016, then surged by 108.88% to $91,109 in 2017, then skyrocketed by 320.72% to $383,310 in 2018, then soared by 160.89% to $1.0 million in 2019, then slumped by 86.46% to $135,405 in 2020.